Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 39.83 CNY 1.66% Market Closed
Market Cap: 18B CNY

Yipinhong Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yipinhong Pharmaceutical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Revenue
ÂĄ1.9B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ12.3B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ10.9B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ28B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
14%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
ÂĄ2B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ5.8B
CAGR 3-Years
94%
CAGR 5-Years
37%
CAGR 10-Years
N/A

Yipinhong Pharmaceutical Co Ltd
Glance View

Market Cap
18.1B CNY
Industry
Pharmaceuticals

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science. The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Intrinsic Value
14.37 CNY
Overvaluation 64%
Intrinsic Value
Price

See Also

What is Yipinhong Pharmaceutical Co Ltd's Revenue?
Revenue
1.9B CNY

Based on the financial report for Sep 30, 2024, Yipinhong Pharmaceutical Co Ltd's Revenue amounts to 1.9B CNY.

What is Yipinhong Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
4%

Over the last year, the Revenue growth was -25%. The average annual Revenue growth rates for Yipinhong Pharmaceutical Co Ltd have been -4% over the past three years , 4% over the past five years .

Back to Top